Silgan Holdings (SLGN)
(Delayed Data from NYSE)
$53.07 USD
+0.43 (0.82%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $53.87 +0.80 (1.51%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$53.07 USD
+0.43 (0.82%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $53.87 +0.80 (1.51%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Zacks News
Silgan Holdings to Grow on Dispensing Systems Acquisition
by Zacks Equity Research
Silgan Holdings (SLGN) anticipated to gain from the Dispensing Systems acquisition, improvement in capital expenditures and lower effective tax rate.
Top Ranked Value Stocks to Buy for March 20th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, March 20th:
Why Silgan Holdings (SLGN) is a Must-Add to Your Portfolio
by Zacks Equity Research
Silgan Holdings' (SLGN) prospects remain bright on the back of solid earnings estimate revision activity as well as an upbeat guidance.
Top Ranked Growth Stocks to Buy for February 13th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 13th:
Top Ranked Growth Stocks to Buy for February 7th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 7th:
Silgan (SLGN) Q4 Earnings Meet Estimates, '18 View Upbeat
by Zacks Equity Research
Silgan Holdings' (SLGN) fiscal 2018 view depicts a 26% rise at the mid-point backed by expectations for improved performance in all its three segments and the impact of the recently passed tax reform.
Will Hurricane Impacts Mar Silgan's (SLGN) Q4 Earnings?
by Zacks Equity Research
Silgan's (SLGN) Q4 results expected to be impacted by higher anticipated resin cost due to the impact of hurricanes.
WestRock (WRK) Q4 Earnings Top on Improved Segment Results
by Zacks Equity Research
WestRock (WRK) continues to make investments to strengthen portfolio, while divesting businesses that are not core to its goal of being a premier provider of paper and packaging solutions.
Silgan (SLGN) Q3 Earnings Miss Estimates, Trims '17 Guidance
by Zacks Equity Research
Silgan Holdings' (SLGN) earnings in 2017 benefited from continued strong performance in the Dispensing Systems operations and plastic container business despite higher resin costs.
Silgan Holdings (SLGN) Down 6.2% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Silgan Holdings (SLGN) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
WestRock (WRK) Q3 Earnings & Revenues Beat on Higher Volumes
by Zacks Equity Research
WestRock Company (WRK) delivered an earnings beat in Q3 aided by higher volumes. The company also remained active on the acquisition front, expanding presence in attractive markets.
WestRock Hits 52-Week High on Robust Capital Allocation
by Zacks Equity Research
WestRock (WRK) hit a 52-week high of $58.62 on Jul 10.
Greif (GEF) Poised to Grow, Slowdown in China Remains a Drag
by Zacks Equity Research
Greif (GEF) is poised to gain from benefit from sale of non-core assets and strong liquidity position.
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Addus HomeCare, Luminex, Silgan Holdings and Two Harbors Investment
by Zacks Equity Research
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Addus HomeCare, Luminex, Silgan Holdings and Two Harbors Investment
Avoid Market Volatility with 5 Low-Beta Stocks
by Zacks Equity Research
In this article, we present a strategy which proves that low risky securities can also reap rewards if some specific parameters are considered.
Here's Why Silgan Holdings (SLGN) Be in Your Portfolio Now
by Zacks Equity Research
In this write-up wwe highlight few points why Silgan Holdings, Inc. (SLGN) is a must-add to your portfolio right now.
Silgan (SLGN) Tops Q1 Earnings, Revenues, Lifts '17 EPS View
by Zacks Equity Research
Silgan's (SLGN) first-quarter 2017 earnings beat the Zacks Consensus Estimate.
WestRock (WRK) Beats on Q2 Earnings, Revenue Estimates
by Zacks Equity Research
WestRock Company's (WRK) second-quarter fiscal 2017 adjusted earnings and revenues beat the respective Zacks Consensus Estimate.
WestRock's (WRK) Q2 Earnings, Revenues Beat Estimates
by Zacks Equity Research
WestRock Company's (WRK) second quarter fiscal 2017 earnings and revenues beat the respective Zacks Consensus Estimates.
Silgan (SLGN) Buys WestRock's Dispensing Systems Business
by Zacks Equity Research
Silgan (SLGN) completed the acquisition of WestRock's dispensing systems business for $1.025 billion.
WestRock Sells Home, Health & Beauty Business to Silgan
by Zacks Equity Research
WestRock Company (WRK) has completed the sale of its Home, Health and Beauty business to Silgan Holdings Inc. (SLGN).
Silgan (SLGN) Scales 52-Week High on a Slew of Positives
by Zacks Equity Research
Silgan (SLGN) hit a 52-week high of $61.46 on Mar 20.
Silgan (SLGN) Q4 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
Silgan Holdings Inc.'s (SLGN) Q4 adjusted earnings of 48 cents came in line with the Zacks Consensus Estimate while revenues lagged.
Silgan to Buy WestRock's Home, Health & Beauty Business
by Zacks Equity Research
Silgan (SLGN) has entered into a definitive agreement with WestRock to buy its Home, Health and Beauty unit for around $1 billion.
WestRock (WRK) Beats on Q1 Earnings, Bolsters Portfolio
by Zacks Equity Research
WestRock Company's (WRK) first-quarter fiscal 2017 adjusted earnings of 47 cents per share beat the Zacks Consensus Estimate.